Peptide Profile
Klotho
alpha-Klotho · a-Klotho · soluble Klotho · KL protein fragment
Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23…
- Routes
- subcutaneous, intravenous
Educational research information — not medical advice. Review primary sources and consult a qualified professional before any decision.
Educational research tools — not medical advice.
What Klotho is
About Klotho
Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.
Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23 (FGF23) and as a systemic anti-aging regulatory factor; circulating alpha-klotho levels decline progressively with age and have been associated with accelerated aging phenotypes, cognitive decline, and increased cardiovascular mortality in large human cohort studies. Soluble klotho exerts pleiotropic protective effects including suppression of IGF-1 and Wnt signaling, reduction of oxidative stress and inflammation, regulation of calcium-phosphate homeostasis via FGF23 co-signaling, and neuroprotective effects relevant to brain aging; mouse models overexpressing klotho live approximately 30% longer while klotho-deficient mice develop premature aging syndromes, establishing it as a key longevity regulator in mammals. Human epidemiological and cohort data — including a systematic review and meta-analysis and a large PNAS cohort study — support significant associations between higher circulating klotho levels and better cognitive performance, lower dementia incidence, and reduced cardiovascular mortality, establishing klotho as a robust human biomarker of healthy aging. Exogenous klotho has no FDA approval and no human interventional trial data; while preclinical administration of recombinant klotho has shown promising anti-aging effects in animal models, the compound remains an active research target rather than an established therapeutic, and its use as an administered agent in humans is not supported by any published clinical evidence.
Klotho Benefits & Research Areas
What the evidence says about Klotho
Research Evidence
based on 12 studies · most recent 2026
Regulatory Status
- Availability Status
- Research Only
- FDA Status
- Not Evaluated
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Research Sources
12 sources cited · 1 strong · 11 moderate
1 Meta-analysis · 10 Cohorts · 1 Review
Klotho heterozygosity does not modify cognitive decline in APOE ε4 carriers: analysis of a large biobank cohort
Proceedings of the National Academy of Sciences · 2025
In a large biobank cohort of 320,861 participants, APOE ε4 homozygous carriers showed significantly greater cognitive decline than heterozygotes; klotho heterozygosity did not independently modify cognitive trajectories after controlling for APOE genotype, providing important context for interpreting klotho's cognitive benefits within the broader longevity genetic risk framework.
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice.
Life (Basel) · 2026
# Summary Research found that VSIG4 expression increases during kidney aging in mice, with this process accelerated in type 2 diabetic mice compared to non-diabetic controls. This study demonstrated that urinary VSIG4 levels correlate strongly with kidney damage markers and may reflect age-related kidney changes, while klotho expression—a known marker of kidney aging—progressively declined over time.
Gene deletion of Klotho in the dentate gyrus does not affect the number of adult-born granule cells.
Sci Rep · 2026
# Summary Research found that removing the Klotho gene specifically in the dentate gyrus—a brain region involved in memory formation—did not alter the production or number of newly generated neurons in adult mice. This study demonstrated that despite Klotho's known roles in aging and neuroprotection, it is not required for maintaining the normal rate of adult neurogenesis in this particular brain structure.
Show 9 more sources ↓
Conserved mRNA expression patterns of the Klotho family in canine mammary tumors and human breast cancer.
Sci Rep · 2026
# Summary Research found that Klotho family members show conserved expression patterns between canine mammary tumors and human breast cancer, with αKlotho and βKlotho reduced and γKlotho overexpressed in tumors, particularly in more aggressive cases. This study demonstrated that γKlotho-high tumors share dysregulated genes and signaling pathways (androgen receptor, VEGF, and ERK) in both species, suggesting Klotho proteins may have similar functional roles in tumor development across humans and dogs.
Vitamin D attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and downregulates hepatic gluconeogenesis in obesity.
J Nutr Biochem · 2026
Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.
Aging Cell · 2026
Association between soluble Klotho levels and calcification propensity T50 in patients with hemodialysis: a cross-sectional study.
Sci Rep · 2026
Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.
Aging Cell · 2026
Research found that microsomal prostaglandin E synthase-2 (mPGES-2) in kidney podocytes acts as a critical regulator of renal aging, and its removal improved kidney function, extended survival, and alleviated age-related bone loss in mice. This study demonstrated that mPGES-2 promotes kidney cell senescence through a specific signaling pathway and identified it as a potential therapeutic target for age-related kidney and bone dysfunction.
From Longevity Genetics to Precision Interventions: Integrating Nutrigenomics and Epigenetic Mechanisms of Ageing.
Genes (Basel) · 2026
The association between exposure to flame retardants and cognitive function in the elderly: Unveiling potential intervention strategies.
Neurotoxicology · 2026
# Summary Research found that serum Klotho levels were statistically associated with both flame retardant exposure and cognitive outcomes in elderly individuals, suggesting that Klotho may serve as a potential mediating factor in the relationship between flame retardant exposure and cognitive decline. This study demonstrated that Klotho could represent a biological mechanism through which flame retardant exposure affects cognitive function, though the researchers noted that further validation through longitudinal and interventional studies is needed to establish causality.
Universal transcriptomic hallmarks of mammalian ageing and mortality.
Nature · 2026
Researchers integrated over 11,000 transcriptomes across four mammalian species to build aging and mortality biomarkers, finding that Klotho deficiency specifically disrupted mitochondrial and metabolic transcriptomic modules—a distinct pattern from caloric restriction—suggesting pathway-specific, subsystem-level effects on mammalian aging regulation.
Klotho protein and cognitive function: a systematic review and meta-analysis
Asian Journal of Psychiatry · 2025
A systematic review and meta-analysis of studies totaling 6,645 participants found a significant positive correlation between klotho protein levels and cognitive function, with subgroup analyses confirming significance for α-klotho measured in serum and plasma, supporting klotho as a biomarker of cognitive aging and a candidate longevity-promoting target.
Klotho Side Effects & Safety Considerations
Research-use compound with limited human data. Evidence strength varies — see the Evidence section.
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.
Compare
VSKlotho
Frequently Asked Questions — Klotho
Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23 (FGF23) and as a systemic anti-aging regulatory factor; circulating alpha-klotho levels decline progressively with age and have been associated with accelerated aging phenotypes, cognitive decline, and increased cardiovascular mortality in large human cohort studies. Soluble klotho exerts pleiotropic protective effects including suppression of IGF-1 and Wnt signaling, reduction of oxidative stress and inflammation, regulation of calcium-phosphate homeostasis via FGF23 co-signaling, and neuroprotective effects relevant to brain aging; mouse models overexpressing klotho live approximately 30% longer while klotho-deficient mice develop premature aging syndromes, establishing it as a key longevity regulator in mammals.
neuroprotection, cardiovascular protection, anti-aging, cognitive support, anti-fibrotic.
Research on Klotho primarily documents effects related to neuroprotection and cardiovascular protection and anti-aging and cognitive support and anti-fibrotic. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.
For Klotho, its FDA status is not evaluated by the FDA, and it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Klotho is tracked across 1 research vendor on PeptideBase, at about $2.00 per mg. This reflects research-use vendor pricing, not clinical or prescription costs.
In a large biobank cohort of 320,861 participants, APOE ε4 homozygous carriers showed significantly greater cognitive decline than heterozygotes; klotho heterozygosity did not independently modify cognitive trajectories after controlling for APOE genotype, providing important context for interpreting klotho's cognitive benefits within the broader longevity genetic risk framework.
How to get Klotho
Market Pricing
1 vendorPrice per mg varies by quantity, vendor type, and formulation. Research use only.
Data verified July 2026 · Klotho price intelligence
Where to buy Klotho
Coverage expanding
No verified providers currently list Klotho. Get notified when one does, or explore providers carrying similar peptides in the Longevity category.
Questions to ask your provider
Stay updated on verified Klotho providers
New verified providers added weekly — delivered to your inbox.
Last updated
Keep exploring
Tools & Guides
Reconstitution Calculator
Convert vial size + BAC water volume into draw volume.
How to Reconstitute Peptides
Step-by-step guide: BAC water, vial prep, and storage after mixing.
Peptide Dosage Guide
Key factors that determine dosing in clinical practice.
Peptide Storage Guide
How to store lyophilized and reconstituted peptides.